Neurogene Inc.
Company Stats
- Market Cap
- $556.7M
- as of Sep 30, 2026
- Shares Outstanding
- 20.0M
- Free Float
- 57.2%
Income Statement
- Revenue
- $0
- Operating Income
- -$103.3M
- Net Income
- -$90.4M
- EBITDA
- -$100.3M
- Non-cash Impairment
- $120,000
Cash Flow
- Free Cash Flow
- -$78.4M
- FCF Yield
- -14.1%
- Owner FCF Yield
- -16.6%
Balance Sheet
- Cash & Equivalents
- $103.8M
Returns & Capital
- SBC, 3Y Avg
- $8.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$78.4M | — |
| FY2024 | $925,000 | -$71.4M | -7720.1% |
| FY2023 | $0 | -$51.7M | — |
| FY2022 | — | -$55.1M | — |
| FY2021 | — | -$50.8M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges